Cytokinetics Inc (CYTK)

Exchange
NASDAQ
Symbol
CYTK
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
Country
USA

Stock price

At close: October 28, 2025

  • Open
    59.88
  • High
    62.15
  • Low
    59.52
  • Close
    61.97
  • Volume
    1,939,490

Financial ratios

Dec 31, 2024